frequent
invas
microorgan
includ
virus
bacteria
fungi
parasit
eukaryot
prokaryot
organ
threaten
continu
threaten
life
health
human
vertebr
recent
year
mutant
new
form
exist
pathogen
identifi
caus
agent
number
outbreak
endang
public
health
china
sever
acut
respiratori
syndrom
sar
caus
coronaviru
spread
throughout
guangdong
provinc
follow
worldwid
epidem
epidem
sar
case
report
china
result
human
death
outbreak
hand
foot
mouth
diseas
hfmd
infect
person
caus
death
three
children
linyi
citi
shandong
provinc
china
influenza
pandem
affect
human
patient
lead
death
china
alon
larg
highli
mobil
popul
emerg
infecti
diseas
china
rel
frequent
therefor
system
implement
medic
commun
govern
monitor
pathogen
could
significantli
neg
impact
public
health
urgent
requir
china
china
establish
hospitalbas
surveil
system
infecti
diseas
clinic
hospit
report
suspect
confirm
case
notifi
infecti
diseas
must
sent
local
center
diseas
control
cdc
inform
sent
china
cdc
headquart
beij
nation
infecti
diseas
monitor
inform
system
databas
establish
hierarch
administr
organ
surveil
system
ensur
rapid
effici
upward
flow
epidem
inform
base
system
develop
effect
diagnost
platform
greatli
enhanc
prevent
control
infecti
diseas
china
predomin
techniqu
identif
microbi
pathogen
depend
convent
clinic
microbiolog
monitor
approach
although
well
establish
approach
usual
requir
cultur
pathogen
follow
suscept
test
timeconsum
labori
addit
mani
microb
difficult
cultur
may
undetect
culturebas
approach
molecular
approach
microbi
surveil
discoveri
emerg
promis
altern
earli
diagnosi
infecti
diseas
current
molecular
approach
includ
tradit
sanger
dna
sequenc
polymeras
chain
reaction
pcr
oligonucleotid
microarray
next
gener
sequenc
ng
among
four
technolog
former
two
identifi
known
pathogen
must
confirm
individu
thu
cover
wide
rang
pathogen
latter
two
method
cover
broad
rang
pathogen
therefor
suitabl
identifi
unknown
even
novel
pathogen
infecti
outbreak
although
ng
produc
indepth
unbias
inform
reveal
complet
novel
organ
timeconsum
expens
especi
analysi
complex
sampl
derisi
colleagu
develop
first
gener
microarray
platform
call
virochip
detect
wide
rang
virus
virochip
help
character
sar
novel
coronaviru
sinc
virochip
also
use
detect
human
metapneumoviru
novel
influenza
viru
novel
adenoviru
recent
greenechip
mda
microarray
develop
broader
spectrum
approach
detect
sever
thousand
pathogen
virus
bacteria
fungi
protozoa
aforement
three
platform
use
long
oligonucleotid
probe
random
amplif
nucleic
acid
studi
report
construct
high
throughput
pathogen
microarray
platform
name
easi
oper
pathogen
microarray
eopm
largescal
pathogen
surveil
discoveri
china
platform
use
similar
technic
featur
previou
method
use
clinic
applic
userfriendli
analysi
softwar
eopm
design
base
latest
version
nucleic
acid
sequenc
resourc
microb
clinic
applic
microarray
system
confirm
correctli
identifi
pathogen
respons
infecti
diseas
releas
european
molecular
biolog
laboratori
embl
http
wwwemblorg
databas
march
use
establish
vertebr
viral
sequenc
databas
term
famili
level
describ
host
vertebr
anim
extract
viru
taxonomi
list
http
ictvonlineorgvirustaxonomyasp
compil
intern
committe
taxonomi
virus
ictvdb
consid
virus
taxonomi
node
also
download
sequenc
fungi
parasit
embl
rrna
sequenc
extract
use
cd
tag
final
obtain
bacteri
rrna
sequenc
ribosom
databas
project
rdp
http
rdpcmemsuedu
final
integr
dataset
includ
viral
sequenc
repres
complet
partial
viral
genom
bacteri
rrna
sequenc
fungal
rrna
sequenc
rrna
sequenc
parasit
eopm
chip
distinguish
known
vertebr
viru
speci
involv
genera
famili
bacteri
genera
involv
famili
fungal
genera
involv
famili
genera
parasit
involv
famili
consid
bacteri
rrna
gene
show
rel
high
level
homolog
bacteria
requir
presenc
activ
virul
gene
pathogenesi
virul
gene
select
includ
rfbe
ipaa
katg
probe
design
gene
sequenc
basic
design
viral
probe
includ
mani
differ
genom
target
region
possibl
speci
vertebr
viru
embldb
first
probe
target
conserv
region
area
encod
structur
protein
protein
famili
databas
pfam
http
pfamsangeracuk
multipl
sequenc
align
use
cluster
function
relat
sequenc
region
tag
utr
utr
ltr
also
extract
use
candid
sequenc
follow
probe
design
second
candid
probe
screen
accord
follow
criteria
probe
length
nt
repeat
exceed
length
nt
hairpin
stem
length
exceed
nt
gc
content
tm
third
use
blast
analysi
select
conserv
viral
probe
genu
level
candid
probe
extent
conserv
evalu
probe
found
detect
major
speci
genu
target
speci
consid
repres
probe
match
least
sequenc
ident
probe
conserv
genu
level
select
base
flexibl
threshold
sequenc
conserv
speci
belong
differ
genera
quit
variabl
final
align
sequenc
candid
probe
nt
databas
download
ncbi
ftp
august
probe
high
sequenc
similar
nontarget
genom
elimin
speciesspecif
genusconserv
probe
includ
final
probe
set
identif
bacteri
fungal
parasit
probe
similar
focus
rrna
sequenc
addit
probe
also
design
target
host
immun
respons
gene
potenti
index
pathogenesi
oligonucleotid
probe
synthes
mm
mm
glass
slide
appli
inkjet
deposit
system
agil
technolog
palo
alto
ca
total
eight
subarray
distinct
probe
one
slide
custom
hybrid
involv
fluorescentlylabel
synthet
oligonucleotid
complementari
posit
control
probe
replic
spot
scatter
differ
zone
subarray
ensur
signal
appear
everi
zone
subarray
facilit
data
extract
hybrid
figur
microbi
nucleic
acid
extract
serum
plasma
throat
swab
nasal
lavag
fece
cerebrospin
fluid
bodi
fluid
use
tianamp
viru
dnarna
kit
tiangen
biotech
beij
china
carrier
rna
kit
appli
extract
viru
nucleic
acid
low
molecular
weight
kit
use
extract
nucleic
acid
rna
dna
virus
like
adenoviru
well
bacteria
fungi
parasit
previous
describ
random
pcr
amplif
strategi
minor
modif
appli
amplifi
extract
nucleic
acid
label
amplifi
product
fluoresc
dye
brief
first
cdna
strand
revers
transcrib
random
decam
heel
pcr
primer
first
strand
cdna
synthes
doublestrand
dna
use
primer
klenow
dna
polymeras
takara
dalian
china
doubl
strand
cdna
patient
normal
control
pcr
amplifi
use
heel
primer
result
pcr
amplicon
purifi
label
normal
control
patient
sampl
respect
use
klenow
polymeras
takara
label
dna
mix
hybrid
buffer
ad
eopm
array
hybrid
overnight
hybrid
oven
agil
eopm
array
wash
ssc
triton
room
temperatur
min
follow
second
wash
ssc
min
array
scan
use
duallas
scanner
agil
imag
extract
analyz
use
featur
extract
softwar
agil
normal
distribut
microb
human
bodi
consid
use
eopm
identifi
pathogen
respons
obviou
clinic
symptom
use
two
strategi
elimin
background
normal
microflora
firstli
experiment
level
alway
compar
suspect
clinic
sampl
normal
sampl
type
ie
serum
vs
serum
fece
vs
fece
secondli
databas
level
compar
clinic
sampl
type
sampl
databas
includ
differ
sampl
normal
popul
serum
fece
cerebrospin
fluid
throat
swab
second
aspect
may
avoid
unexpect
issu
experiment
normal
control
strategi
clinic
sampl
first
compar
normal
control
normal
sampl
databas
potenti
pathogen
identifi
base
increas
distribut
compar
normal
human
sampl
facilit
applic
eopm
multipl
surveil
site
infecti
diseas
design
softwar
userfriendli
interfac
support
statist
analysi
method
base
comprehens
microbi
sequenc
identif
databas
microbi
diagnost
microarray
probe
design
target
microb
probe
confirm
specif
posit
neg
sampl
panmicrobi
microarray
mani
probe
design
one
pathogen
way
confirm
probe
howev
major
probe
target
expect
pathogen
like
posit
hybrid
nontarget
microb
appli
hypergeometr
distribut
calcul
pvalu
speci
assess
statist
signific
whether
pathogen
significantli
present
determin
use
complex
interpret
method
formula
hypergeometr
distribut
function
follow
n
c
stand
combin
formula
n
whole
number
microbi
probe
array
number
probe
target
microb
n
number
probe
intens
posit
array
number
probe
whose
intens
posit
target
microb
probe
rank
signal
fluoresc
dye
use
label
patient
sampl
userinterfac
eopm
softwar
proport
probe
chosen
user
accord
sampl
type
small
pvalu
indic
low
likelihood
mistak
occur
multiprob
analysi
correspondingli
high
probabl
exist
target
microb
final
pvalu
adjust
use
benjamini
hochberg
fdr
correct
probe
design
speci
genu
level
result
given
accordingli
eopm
analysi
least
three
posit
probe
specif
speci
pathogen
enrich
pvalu
given
speci
could
consid
posit
investig
includ
clinic
symptom
coincid
analysi
molecular
detect
method
includ
panmicrobi
microarray
unbias
high
throughput
sequenc
tradit
reli
random
amplif
lower
sensit
specif
pcr
clinic
sampl
usual
contain
host
nucleic
acid
may
interfer
sensit
microarray
analysi
determin
sensit
epom
spike
viral
rna
human
rna
mimick
actual
clinic
sampl
enteroviru
singlestrand
rna
viru
cultur
vero
cell
rna
cultur
supernat
medium
extract
quantit
determin
use
qrtpcr
standard
curv
molecul
spike
rna
extract
human
hela
cell
rna
randomli
amplifi
hybrid
eopm
microarray
describ
parallel
rtpcr
use
pair
specif
primer
amplifi
perform
compar
sensit
two
method
known
pathogen
includ
cellcultur
viral
refer
strain
cultur
bacteria
fungi
use
verifi
eopm
perform
clinic
sampl
patient
obviou
infecti
diseas
symptom
obtain
neg
result
routin
diagnost
method
follow
detect
eopm
screen
pathogen
caus
similar
clinic
symptom
patient
clinic
sampl
collect
pcr
amplifi
speci
genusspecif
primer
pcrposit
sampl
sequenc
studi
obtain
ethic
approv
ethic
committe
guangdong
women
children
hospit
inform
consent
requir
clinic
sampl
screen
potenti
pathogen
vitro
origin
microarray
data
submit
gene
express
omnibu
platform
access
number
high
throughput
microarray
long
oligonucleotid
probe
virochip
greenechip
system
prove
effect
pathogen
screen
eopm
techniqu
describ
also
use
long
oligonucleotid
probe
random
pcr
amplif
sever
known
virus
bacteria
fungi
use
evalu
accuraci
eopm
dengu
viru
use
test
subject
determin
whether
eopm
method
could
detect
viru
infect
cell
cultur
tabl
shown
tabl
among
top
rank
probe
eight
target
dengu
viru
specif
four
probe
target
relat
flavivirues
phnom
penh
bat
viru
tembusu
viru
deer
tick
viru
also
carri
enrich
analysi
posit
probe
speci
genu
level
notabl
dengu
viru
close
relat
speci
show
signific
enrich
tabl
flaviviru
show
signific
enrich
genu
level
adjust
pvalu
tabl
result
consist
known
cultur
dengu
viru
follow
similar
procedur
success
test
eopm
panel
known
pathogen
includ
rna
viru
dna
viru
bacteria
fungi
parasit
list
tabl
term
detect
sensit
eopm
could
reliabl
detect
copi
rna
mix
copi
hela
cell
rna
copi
spike
viru
rna
could
detect
copi
host
rna
specif
rtpcr
follow
agaros
gel
electrophoresi
therefor
infer
high
level
background
nucleic
acid
detect
sensit
random
primer
amplif
three
order
magnitud
lower
specif
primer
amplif
adenoviru
infect
caus
similar
symptom
induc
respiratori
virus
mycoplasma
make
difficult
identifi
pathogen
tradit
clinic
diagnost
procedur
februari
outbreak
diseas
caus
unknown
pathogen
occur
baod
citi
hebei
provinc
patient
present
obviou
infecti
symptom
high
fever
cough
throat
congest
lung
tissu
necrosi
bronchopneumonia
initi
influenza
viru
sar
viru
mycoplasma
known
caus
clinic
symptom
suspect
pcr
test
neg
three
pathogen
rapidli
identifi
unknown
pathogen
eopm
chip
select
screen
possibl
pathogen
respons
infect
nucleic
acid
extract
patient
serum
sampl
use
eopm
analysi
nucleic
acid
normal
serum
use
control
one
scan
microarray
imag
shown
figur
enrich
result
toprank
pathogen
speci
genu
level
list
tabl
respect
adenovirus
found
significantli
enrich
top
five
speci
result
tabl
verifi
adenoviru
caus
agent
pcr
target
conserv
region
mastadenoviru
genom
sequenc
see
addit
file
handfootandmouth
diseas
hfmd
common
viral
ill
predominantli
affect
infant
children
younger
year
old
hfmd
epidem
usual
occur
china
late
spring
earli
summer
pathogen
respons
hfmd
mainli
coxsacki
viru
enteroviru
belong
enteroviru
genu
routin
hfmd
clinic
diagnosi
includ
three
qrtpcr
kit
target
enteroviru
genu
speci
respect
may
mani
children
found
clinic
symptom
handfootandmouth
diseas
guangdong
women
children
hospit
locat
southern
china
although
patient
diagnos
infect
qrtpcr
analysi
neg
enteroviru
identifi
pathogen
respons
enterovirusneg
hfmd
children
sampl
patient
subject
eopm
analysi
mg
fece
sampl
use
extract
rna
use
tianamp
viru
dnarna
kit
label
follow
random
amplif
parallel
rna
extract
normal
fece
label
use
control
enrich
analysi
speci
level
identifi
theiler
slike
cardioviru
probabl
pathogen
respons
hfmd
infect
patient
tabl
analysi
enrich
result
genu
level
reveal
cardioviru
number
one
match
show
signific
enrich
tabl
genera
cardioviru
enteroviru
belong
famili
picornavirida
famili
posit
singlestrand
rna
virus
intestin
virus
picornavirida
famili
besid
entervirus
strain
coxsacki
viru
enteroviru
also
known
potenti
caus
hfmd
syndrom
therefor
hypothes
enterovirusneg
hfmd
children
actual
infect
cardioviru
sister
genu
enteroviru
confirm
presenc
cardioviru
patent
fece
two
specif
nest
rtpcr
primer
propos
previou
report
use
amplifi
rna
extract
enterovirusneg
patient
sampl
cardiovirusposit
see
addit
file
pcr
product
verifi
dna
sequenc
bp
pcr
amplicon
share
nucleotid
ident
human
tmevlik
cardioviru
isol
utr
microarray
raw
data
symptomcaus
pathogen
streptococcu
mycoplasma
identifi
eopm
peripher
blood
infecti
patient
also
submit
geo
databas
primari
purpos
develop
eopm
facilit
rapid
identif
unknown
pathogen
region
surveil
center
china
emerg
pathogencaus
incid
occur
consid
applic
microarray
technolog
data
analysi
signific
obstacl
user
without
special
knowledg
bioinformat
analysi
microarray
data
nucleic
acid
sequenc
therefor
implement
statist
enrich
analysi
userfriendli
interfac
figur
softwar
support
largescal
search
probe
hit
comprehens
microbi
sequenc
databas
believ
softwar
greatli
facilit
instal
eopm
platform
differ
infecti
surveil
system
laboratori
china
softwar
access
http
sinc
first
applic
highthroughput
rapid
unbias
microarray
detect
viral
pathogen
sever
panmicrobi
microarray
platform
differ
degre
coverag
variou
pathogen
establish
microarray
platform
use
long
oligonucleotid
probe
random
pcr
amplif
success
identifi
unexpect
pathogen
infecti
diseas
outbreak
even
discov
novel
virus
homolog
known
speci
studi
construct
highdens
eopm
array
screen
known
virus
bacteria
fungi
parasit
could
becom
vertebr
pathogen
base
sequenc
data
avail
vertebr
pathogen
design
oligonucleotid
probe
target
vertebr
viru
speci
involv
genera
famili
bacteri
genera
involv
famili
fungal
genera
involv
famili
parasit
genera
involv
famili
oligonucleotid
probe
crosshybrid
similar
nonident
sequenc
allow
detect
novel
pathogen
relat
known
speci
eopm
probe
design
detect
bacteria
fungi
parasit
target
rrna
rrna
sequenc
wherea
rrna
sequenc
rel
conserv
genu
famili
eopm
distinguish
bacteria
fungi
parasit
either
genu
famili
level
alreadi
success
appli
clinic
set
confirm
treatment
sensit
studi
eopm
design
experi
compar
sensit
random
amplif
specif
amplif
consid
effect
issu
clinic
sampl
collect
nucleic
acid
extract
sensit
eopm
eopm
show
lower
sensit
specif
target
pcr
amplif
consist
previou
report
lower
sensit
due
random
pcr
amplif
adopt
eopm
sampl
prepar
effici
specif
pcr
amplif
particular
speci
despit
lower
sensit
targetspecif
pcr
eopm
platform
suffici
sensit
identifi
pathogen
caus
clinic
symptom
infecti
outbreak
symptomcaus
pathogen
highli
enrich
sensit
improv
practic
acellular
sampl
minim
host
nucleic
acid
contamin
serum
throat
swab
use
pathogen
screen
exampl
grening
colleagu
use
virochip
microarray
identifi
influenza
nasal
swab
sampl
show
compar
sensit
rtpcr
sampl
prepar
eopm
method
rna
dna
extract
sampl
firstli
revers
transcrib
rna
virus
convert
cdna
dna
virus
keep
dna
statu
revers
transcript
reaction
dna
includ
reversetranscrib
cdna
origin
dna
virus
transform
doubl
strand
dna
subsequ
random
amplif
procedur
therefor
eopm
detect
rna
virus
dna
virus
standard
protocol
bacteria
fungi
parasit
eopm
detect
rrna
rrna
copi
encod
rrna
gene
locat
genom
dna
rrna
gene
highli
transcrib
detect
rrna
molecul
instead
rrna
gene
achiev
higher
sensit
dual
color
strategi
use
eopm
method
one
normal
sampl
without
infecti
symptom
alway
analyz
parallel
despit
normal
sampl
may
possess
clinic
characterist
exampl
found
torqu
teno
viru
human
endogen
retrovirus
normal
blood
sampl
virus
caus
obviou
clinic
symptom
interfer
aim
eopm
analysi
determin
possibl
pathogen
caus
symptom
test
patient
eopm
data
analysi
consist
two
step
first
screen
significantli
enrich
microb
target
sampl
compar
normal
sampl
use
dual
color
chip
second
predict
microb
identifi
first
step
compar
databas
compil
normal
popul
mention
elimin
background
microb
also
exist
normal
sampl
without
infecti
symptom
panmicrobi
screen
microarray
differ
nucleic
acidbas
microbi
diagnost
technolog
qpcr
low
densiti
microarray
diagnost
technolog
mere
aim
identifi
one
type
microb
use
targetspecif
probe
confirm
specif
posit
nonspecif
sampl
moreov
diagnost
lowdens
microarray
usual
use
short
oligonucleotid
specif
probe
similar
taqman
probe
qpcr
technolog
limit
number
short
probesprim
target
pathogen
could
fail
detect
sequenc
mutat
locat
region
target
probesprim
howev
dozen
long
oligonucleotid
probe
design
pathogen
eopm
method
allow
reliabl
identif
pathogen
base
statist
enrich
analysi
probe
group
instead
one
individu
probe
moreov
eopm
effect
narrow
potenti
pathogen
even
identifi
novel
pathogen
complex
clinic
infect
situat
addit
pathogen
sequenc
host
immun
respons
gene
also
includ
eopm
databas
eopm
analysi
clinic
sampl
immun
respons
gene
show
dramat
downregul
target
sampl
compar
normal
refer
data
shown
far
found
reliabl
relationship
immun
respons
gene
pathogen
categori
overal
clinic
inform
patient
normal
control
also
comprehens
analyz
human
immun
relat
gene
peripher
blood
show
dramat
differ
express
even
normal
popul
differ
correl
sex
age
sampl
time
amongst
factor
avail
genomewid
technolog
detect
unknown
pathogen
infecti
outbreak
primarili
consist
microarray
ng
although
ng
provid
indepth
unbias
inform
reveal
complet
novel
pathogen
timeconsum
sampl
contain
hundr
microbi
speci
requir
comprehens
data
process
therefor
ng
meet
short
time
requir
infecti
diseas
control
howev
complic
step
eopm
technolog
probe
design
undertaken
core
bioinformat
team
develop
phase
probe
design
complet
whole
microarray
procedur
optim
standard
procedur
pathogen
screen
result
interpret
less
hour
therefor
eopm
suitabl
applic
requir
detect
unknown
pathogen
infecti
outbreak
addit
rapid
increas
microbi
metagenom
sequenc
data
produc
ng
probe
use
eopm
easili
upgrad
eopm
version
updat
due
situ
synthesi
technolog
replac
spot
technolog
microarray
fabric
conclus
eopm
power
panmicrobi
detect
microarray
platform
detect
almost
known
pathogen
relat
speci
sever
clinic
test
applic
found
eopm
technolog
sensit
enough
detect
pathogen
caus
evid
clinic
symptom
eopm
design
easi
oper
detect
softwar
contain
userfriendli
interfac
facilit
applic
molecular
laboratori
infecti
diseas
epidem
emerg
frequent
china
believ
use
eopm
main
pathogen
surveil
site
across
countri
could
play
import
role
infecti
diseas
control
china
patent
pend
author
relat
probe
design
method
array
data
statist
enrich
method
addit
softwar
copyright
pend
relat
pathogen
interpret
lz
yj
conceiv
studi
analyz
data
lz
draft
manuscript
wh
yy
conduct
microarray
experi
pcr
sequenc
confirm
xz
hl
design
probe
softwar
xz
ay
cz
zh
particip
sampl
collect
array
data
analysi
author
read
approv
final
manuscript
prepubl
histori
paper
access
http
